ATNM
Price
$1.30
Change
-$0.09 (-6.47%)
Updated
Apr 4, 02:26 PM (EDT)
Capitalization
47.42M
38 days until earnings call
PLRX
Price
$1.29
Change
-$0.02 (-1.53%)
Updated
Apr 4, 02:49 PM (EDT)
Capitalization
80.53M
38 days until earnings call
Ad is loading...

ATNM vs PLRX

Header iconATNM vs PLRX Comparison
Open Charts ATNM vs PLRXBanner chart's image
Actinium Pharmaceuticals
Price$1.30
Change-$0.09 (-6.47%)
Volume$1.2K
Capitalization47.42M
Pliant Therapeutics
Price$1.29
Change-$0.02 (-1.53%)
Volume$297
Capitalization80.53M
ATNM vs PLRX Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. PLRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and PLRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATNM: $1.39 vs. PLRX: $1.31)
Brand notoriety: ATNM and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 43% vs. PLRX: 33%
Market capitalization -- ATNM: $47.42M vs. PLRX: $80.53M
ATNM [@Biotechnology] is valued at $47.42M. PLRX’s [@Biotechnology] market capitalization is $80.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATNM is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • PLRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -26.46% price change this week, while PLRX (@Biotechnology) price change was -13.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

ATNM is expected to report earnings on May 12, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($80.5M) has a higher market cap than ATNM($47.4M). ATNM YTD gains are higher at: 10.317 vs. PLRX (-90.053). ATNM has higher annual earnings (EBITDA): -44.15M vs. PLRX (-205.16M). PLRX has more cash in the bank: 356M vs. ATNM (78.7M). ATNM has less debt than PLRX: ATNM (1.71M) vs PLRX (60.2M). ATNM has higher revenues than PLRX: ATNM (81K) vs PLRX (0).
ATNMPLRXATNM / PLRX
Capitalization47.4M80.5M59%
EBITDA-44.15M-205.16M22%
Gain YTD10.317-90.053-11%
P/E RatioN/AN/A-
Revenue81K0-
Total Cash78.7M356M22%
Total Debt1.71M60.2M3%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 5 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZAGF644.5041.16
+6.82%
Lonza Group AG
TMICY66.030.19
+0.29%
Trend Micro Inc.
CWGL5.77-0.03
-0.52%
Crimson Wine Group Ltd.
SSLZY4.05-0.20
-4.71%
Santos Ltd.
PLNH0.23-0.02
-8.00%
Planet 13 Holdings Inc.

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-8.55%
GBIO - ATNM
46%
Loosely correlated
+7.37%
LOGC - ATNM
43%
Loosely correlated
-3.50%
ABOS - ATNM
33%
Loosely correlated
-8.52%
PLRX - ATNM
33%
Loosely correlated
-7.09%
IMNM - ATNM
33%
Loosely correlated
-7.00%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-7.09%
LXRX - PLRX
43%
Loosely correlated
-11.91%
ITRM - PLRX
41%
Loosely correlated
-4.10%
SRRK - PLRX
41%
Loosely correlated
-5.65%
FHTX - PLRX
40%
Loosely correlated
-7.89%
CRGX - PLRX
37%
Loosely correlated
-3.07%
More